Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. - Wikidata - wikimedia - TriplyDB

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

http://www.wikidata.org/entity/Q34149151

about

The AP-2 family of transcription factors Melanoma: from melanocyte to genetic alterations and clinical options AP-2alpha Inhibits c-MYC Induced Oxidative Stress and Apoptosis in HaCaT Human Keratinocytes Sumoylation pathway is required to maintain the basal breast cancer subtype Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene TFAP2A mutations result in branchio-oculo-facial syndrome Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells Role of retinoids in the prevention and treatment of colorectal cancer Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2 Cell autonomous roles for AP-2alpha in lens vesicle separation and maintenance of the lens epithelial cell phenotype CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.New insights into the regulation of human cytotrophoblast cell differentiation.Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity.Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development.WWOX gene and gene product: tumor suppression through specific protein interactions.Driving transcriptional regulators in melanoma metastasis.Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.Classification of polycyclic aromatic hydrocarbons based on mutagenicity in lung tissue through DNA microarray.Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells.miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.

P2860

Q21184171-EBD60B08-F99D-49F2-B7AC-2C4D3098E79B Q21284811-B53A2437-AA0E-406F-A920-D94D970FDD8C Q24294722-197588F1-3DFD-4001-95BE-B94669B455D6 Q24297866-CB696711-7035-4698-92F0-ACBEF242DC8A Q24307618-DFBF1726-0907-4184-8E76-B18FA68F5F73 Q24530625-88CECEA5-4D3A-4CD4-858B-5824DC94C2A4 Q24616799-AF97BC48-C4E9-4580-8B00-7FF2344AC578 Q24626014-DD3C6660-12E1-4202-AF30-BE51FB555258 Q24651305-F9CF681F-33DA-4FE5-927B-90E458459214 Q24655671-4E2260B0-0713-47AA-9F78-B98C81F0426A Q24657263-6E9A8869-9084-4594-8268-A5A74D94A401 Q24676129-DC166611-CECE-4407-817C-3F64FE32307E Q26781463-EEBB17CD-97C0-48F7-9BA9-FF07852B2DFD Q28480575-1F3D7D06-1A7D-4230-84DD-BFA63CA8E82E Q28506671-A9EAF2A9-5A1B-440B-9040-DC3421445E3F Q30988544-7A264DD1-DE77-49DF-A77A-AA9954ACB19A Q33575481-C1B69FDB-C928-4A92-846F-A3E2734074C8 Q33595109-9BE8AE01-2D8A-45B1-A79B-4ABB6C9F491E Q33613510-19A2C5F0-A606-4535-9C7D-FF63084403EC Q33627215-7C2FA34B-10EC-4EAE-9E0F-DE4E955A7912 Q33734760-6E57A965-CAC7-4D24-843D-214C7153B0B7 Q33867103-6AD2FCDD-EC9F-4EB6-8A0C-EDE307C6A157 Q33871764-0097783F-DC38-4B10-BAB4-2E7E2ED4C752 Q34005395-632A1D31-F8C2-4741-91CF-534ACCE15780 Q34231008-86E4BD97-8416-4CE1-B6C3-9C258DA67C66 Q34405013-51297832-1510-4719-BF69-70D78C8DA9A9 Q34517383-2B72AE3A-DB63-40FC-8503-C46AA060AF77 Q35817482-C8100228-687B-49E0-A6EE-F70011B68258 Q35908991-19773257-7940-4397-8C35-5FCF146298FE Q36467928-0E5CC34B-AACA-47F2-B1F3-FBDEB12882A2 Q36720814-EE3A239D-FD6C-4D83-8954-D5853CA3CECA Q36748207-019CE615-0806-44D1-834F-3C6387828696 Q37020835-BCD43143-91D1-4E59-9B51-ADE04FB8A683 Q37668700-117A7606-D13D-4E12-A523-0C8F1311F4B0 Q37690302-4C08D541-AF17-4FCF-8117-2413D6F15D15 Q38017594-38C58113-DCAA-4319-90EB-1D0075A5A5EA Q38356684-09973677-65AF-4AFD-ADDC-09D075F72547 Q38500950-5A1054F0-8175-40A0-92F1-8FBF1B14199B Q38701263-7BFB9D63-0BA4-469C-9F5F-6178F6103924 Q38913109-8651774A-D883-42D8-907F-F0C34DE83488

P2860

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

http://www.wikidata.org/entity/Q34149151

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@ast

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@en

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@nl

type

label

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@ast

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@en

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@nl

prefLabel

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@ast

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@en

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@nl

P1433

Q34149151-0DFBCF81-F937-4DE5-A8BF-6A683DA5F535

P1476

Q34149151-3B3A9A61-3D79-4681-8F0A-8128046E0258

P2093

Q34149151-3B12F975-D816-4BD3-9DAD-525ED124323E

Q34149151-98AA8D13-4814-41DF-B10C-F2ABC11CEA67

Q34149151-B9A82A20-6E17-45CA-8BA8-C271504BFC49

P2860

Q34149151-0C558691-42AD-41B3-9458-21D27767E704

Q34149151-0F7D3B59-2F12-458C-A2B5-5BA573DFFF7A

Q34149151-28788B4B-9B84-4681-B002-29CB38AF2010

Q34149151-2F1C7ACF-EC53-4B1F-B94F-563B7A9DA051

Q34149151-31AC8F7B-D47C-45E7-AEFB-6BA791F81997

Q34149151-43F84E0D-3996-4099-AEDA-76C440E359AE

Q34149151-49C09452-1805-4CB5-B05E-5041810C33C1

Q34149151-4AA12835-D36F-4728-B0D9-82CA45822C2B

Q34149151-5515648C-62A4-45F8-9C45-003092B95F57

Q34149151-6D98571E-F6AF-4DB0-B730-74A3864495F7

P304

Q34149151-B72EAF13-6751-4F48-9354-F01E575D9770

P31

Q34149151-E7142DD6-5D75-420B-AD36-155C94CC145B

P356

Q34149151-94158D33-A2EF-4691-AA97-E1FB88980992

P407

Q34149151-123801CE-AA02-4437-A421-94E1707DD976

P433

Q34149151-1BB01C08-AE03-4C5D-A754-F3E8879B6219

P478

Q34149151-E0EB4B51-AC2E-4F43-B754-098A4CE605A2

P577

Q34149151-66AF3868-A7A9-4CAA-A84E-5DC6C88913BF

P698

Q34149151-EB919757-A8D4-4898-B034-56487F282B33

P356

P1433

Journal of Biological Chemistry

P1476

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

@en

P2093

Alexander V Loktev

http://www.w3.org/2001/XMLSchema#string

Lisa A McPherson

http://www.w3.org/2001/XMLSchema#string

Ronald J Weigel

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of ERF-1 as a member of the AP2 transcription factor family

WAF1, a potential mediator of p53 tumor suppression

Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control

Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family

Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties

AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice

AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle

Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta

Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

P304

45028-45033

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M208924200

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12226108

http://www.w3.org/2001/XMLSchema#string